Wednesday , 17 April 2024
Home COVID-19 Coronavirus: India reserves Rs. 50,000 crore for vaccinating entire country
COVID-19

Coronavirus: India reserves Rs. 50,000 crore for vaccinating entire country

The Indian government has reportedly set aside Rs. 50,000 crore to ensure that the COVID-19 vaccine reaches the entire country.

People familiar with the matter told Bloomberg that the Prime Minister Narendra Modi administration has set aside $6-7 (around Rs. 500) for each of the country’s 1.3 billion people.

India is expecting a COVID-19 vaccine to be ready by early next year.

$4 per person reserved for vaccine; $2-3 for infrastructure

The government has estimated a figure of $7 billion to vaccinate the entire country, sources told Bloomberg.

The funds have been set aside for the current financial year, ending March 31. There will be no shortage for further funds, they said.

The government has calculated that two doses of the vaccine will cost $2/shot, and infrastructure costs—such as storage and transport—will cost $2-3/person.

Modi recently assured nationwide access to vaccines

Speaking to the nation on Tuesday, Modi said the government will ensure all Indians have access to a COVID-19 vaccine as soon as possible.

A government-appointed panel has concluded that India is past its COVID-19 peak and may contain the infection by February.

However, Modi and the experts have cautioned that infections may spike again during the ongoing festive season.

India has reported 77 lakh coronavirus infections

Meanwhile, as of 8 am on Thursday, India had reported 77,06,946 COVID-19, according to the Union Health Ministry’s data. Out of these, 7,15,812 are active infections while 68,74,518 people have recovered since the beginning of the pandemic. The death toll is 1,16,616.

SII estimates Rs. 80,000 crore required for vaccination

On a related note, Serum Institute of India CEO Adar Poonawalla has said that India would need Rs. 80,000 crore for procuring and inoculating the whole population.

The SII is the world’s largest vaccine manufacturer and is currently working on the production of Oxford-AstraZeneca’s frontrunner vaccine candidate.

Biocon founder Kiran Mazumdar-Shaw added that India’s biggest challenge is setting up cold-chain logistics to distribute vaccines.

Leave a comment

Related Articles

Covid cases showing signs of increase in Maharashtra

Covid-19 cases are showing signs of increase in Maharashtra after a long lull, while...

Physical Activity Aids Cognitive Development in Children

Covid-19 has forced all of us, including the children, to completely change...

Blue Dart aircraft flying international stand strong with the nation against the COVID-19 pandemic

Blue Dart has been facilitating the transport of oxygen concentrators amongst other...

Rentokil Initial Extends Support To India’s Frontline Workers

Rentokil Initial as part of its commitment to support India’s efforts to...